유전성 혈관부종의 진단과 치료: 전문가 의견서

키워드

참고문헌 (66)

1. Maurer M, "The international WAO", EAACI guideline for the management of hereditary angioedema-The 2021 revision and update, 2022, ~
2. Bork K, "Hereditary angioedema : new findings concerning symptoms, affected organs, and course", Am J Med, 119, pp.267~274 (2006)
3. Maurer M, "Differences and similarities in the mechanisms and clinical expression of bradykinin-mediated vs. mast cell-mediated angioedema", Clin Rev Allergy Immunol, 61, pp.40~49 (2021)
4. Cicardi M, "Angioedema due to bradykinin dysregulation", J Allergy Clin Immunol Pract, 6, pp.1132~1141 (2018)
5. Bygum A, "Hereditary angio-oedema in Denmark : a nationwide survey", Br J Dermatol, 161, pp.1153~1158 (2009)
6. Germenis AE, "Speletas, genetics of hereditary angioedema revisited", Clin Rev Allergy Immunol, 51, pp.170~182 (2016)
7. Magerl M, "Hereditary angioedema with normal C1 inhibitor : update on evaluation and treatment", Immunol Allergy Clin North Am, 37, pp.571~584 (2017)
8. Hoover T, "Angiotensin converting enzyme inhibitor induced angio-oedema : a review of the pathophysiology and risk factors", Clin Exp Allergy, 40, pp.50~61 (2010)
9. Iwamoto K, "National prevalence survey of hereditary angioedema in Japan", Arerugi, 60, pp.26~32 (2011)
10. Lei WT, "Type I hereditary angioedema in Taiwan--clinical, biological features and genetic study", Asian Pac J Allergy Immunol, 29, pp.327~331 (2011)
11. Ren HL, "Clinical features of hereditary angioedema : analysis of 133 cases", Zhonghua Yi Xue Za Zhi, 87, pp.2772~2776 (2007)
12. Lee JH, "A case of hereditary angioedema", Allergy, 14, pp.695~701 (1994)
13. Lee YS, "A case of hereditary angioedema", Korean J Dermatol, 32, pp.115~118 (1994)
14. Suh KS, "Three cases of hereditary angioedema in one family", Korean J Dermatol, 33, pp.564~569 (1995)
15. Lee JA, "A case of hereditary angioedema not manifestated classical autosomal dominant trait", Korean J Allergy, 17, pp.574~579 (1997)
16. Ha CY, "A case of acquired angioedema with C1 esterase inhibitor deficiency", J Asthma Allergy Clin Immunol, 19, pp.224~228 (1999)
17. Kim SH, "A case of hereditary angioedema associated with idiopathic hypoparathyroidism", Korean J Intern Med, 16, pp.281~283 (2001)
18. Lim YC, "Hereditary angioneurotic edema of the larynx", Acta Otolaryngol, 125, pp.1240~1243 (2005)
19. 심대보, "후두에 발생한 유전성 혈관부종 1예", 대한이비인후-두경부외과학회지, 49(4), pp.464~467 (2006), 대한이비인후과학회
20. 이준규, "두경부 혈관부종에 대한 임상적 고찰", 대한이비인후-두경부외과학회지, 51(8), pp.726~730 (2008), 대한이비인후과학회
21. 정진영, "Migraine-like Headache in a Patient with Complement 1 Inhibitor Deficient Hereditary Angioedema", Journal of Korean Medical Science, 27(1), pp.104~106 (2012), 대한의학회
22. 이서영, "유전성 혈관부종 환자에서의 성공적인 제왕절개 분만 1예", 천식 및 알레르기, 32(4), pp.264~267 (2012), 대한천식알레르기학회
23. 신미용, "A Case of Hereditary Angioedema in a 7-Year-Old Korean Girl", Allergy, Asthma & Immunology Research, 5(1), pp.59~61 (2013), 대한천식알레르기학회
24. 심다운, "A Case of Type 2 Hereditary Angioedema With SERPING1 Mutation", Allergy, Asthma & Immunology Research, 9(1), pp.96~98 (2017), 대한천식알레르기학회
25. 황유경, "Icatibant로 급성 악화를 치료한 제2형 유전성혈관부종 1예", Allergy Asthma & Respiratory Disease, 9(3), pp.180~183 (2021), 대한 소아알레르기 호흡기학회[DOI]
26. Park Jeong Wook, "Capillary leak syndrome and disseminated intravascular coagulation after kidney transplantation in a patient with hereditary angioedema - A case report -", Anesthesia and Pain Medicine, 16(1), pp.75~80 (2021), 대한마취통증의학회[DOI]
27. 방윤식, "An anesthetic experience of hereditary angioedema type I patient undertook total laparoscopic hysterectomy - A case report -", Anesthesia and Pain Medicine, 17(2), pp.235~238 (2022), 대한마취통증의학회[DOI]
28. Kang HR, "Normal C1 inhibitor mRNA expression level in type I hereditary angioedema patients : newly found C1 inhibitor gene mutations", Allergy, 61, pp.260~264 (2006)
29. 이서영, "설문조사를 통한 국내 유전성 혈관부종 진료 현황 및 국내 사례 문헌고찰", Allergy Asthma & Respiratory Disease, 2(4), pp.277~284 (2014), 대한 소아알레르기 호흡기학회
30. Jung JW, "Clinical features of hereditary angioedema in Korean patients : a nationwide multicenter study", Int Arch Allergy Immunol, 176, pp.272~279 (2018)
31. Zuraw B, "Pathogenesis and laboratory diagnosis of hereditary angioedema", Allergy Asthma Proc, 30, pp.487~492 (2009)
32. Valle SOR, "Hereditary angioedema : screening of first-degree blood relatives and earlier diagnosis", Allergy Asthma Proc, 40, pp.279~281 (2019)
33. Zingale LC, "Acquired deficiency of the inhibitor of the first complement component : presentation, diagnosis, course, and conventional management", Immunol Allergy Clin North Am, 26, pp.669~690 (2006)
34. Sobotkova M, "Acquired angioedema with C1 inhibitor deficiency : occurrence, clinical features, and management : a nationwide retrospective study in the Czech Republic patients", Int Arch Allergy Immunol, 182, pp.642~649 (2021)
35. Gobert D, "Acquired angioedema due to C1-inhibitor deficiency : CREAK recommendations for diagnosis and treatment", Rev Med Interne, 41, pp.838~842 (2020)
36. Gobert D, "A nationwide study of acquired C1-inhibitor deficiency in France : characteristics and treatment responses in 92 patients", Medicine(Baltimore), 95, pp.e4363~ (2016)
37. 조효정, "Clinical Characteristics of Angioedema With Eosinophilia", Allergy, Asthma & Immunology Research, 6(4), pp.362~365 (2014), 대한천식알레르기학회
38. Weller PF, "The idiopathic hypereosinophilic syndrome", Blood, 83, pp.2759~2779 (1994)
39. Zanichelli A, "Efficacy of on-demand treatment in reducing morbidity in patients with hereditary angioedema due to C1 inhibitor deficiency", Allergy, 70, pp.1553~1558 (2015)
40. Magerl M, "Characterization of prodromal symptoms in a large population of patients with hereditary angio-oedema", Clin Exp Dermatol, 39, pp.298~303 (2014)
41. Prematta MJ, "Per-attack reporting of prodromal symptoms concurrent with C1-inhibitor treatment of hereditary angioedema attacks", Adv Ther, 29, pp.913~922 (2012)
42. Rasmussen ER, "Urticaria and prodromal symptoms including erythema marginatum in Danish patients with hereditary angioedema", Acta Derm Venereol, 96, pp.373~376 (2016)
43. Wentzel N, "Fresh frozen plasma for on-demand hereditary angioedema treatment in South Africa and Iran", World Allergy Organ J, 12, pp.100049~ (2019)
44. Boccon-Gibod I, "Safety and efficacy of icatibant self-administration for acute hereditary angioedema", Clin Exp Immunol, 168, pp.303~307 (2012)
45. Javaud N, "Factors associated with hospital admission in hereditary angioedema attacks : a multicenter prospective study", Ann Allergy Asthma Immunol, 114, pp.499~503 (2015)
46. Bork K, "Efficacy of different medical therapies for the treatment of acute laryngeal attacks of hereditary angioedema due to C1-esterase inhibitor deficiency", J Emerg Med, 50, pp.567~580 (2016)
47. Simon TL, "Manufacturing of plasma-derived C1-inhibitor concentrate for treatment of patients with hereditary angioedema", Allergy Asthma Proc, 41, pp.99~107 (2020)
48. Reshef A, "Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children", Pediatr Allergy Immunol, 30, pp.562~568 (2019)
49. Farkas H, "Icatibant as acute treatment for hereditary angioedema in adults", Expert Rev Clin Pharmacol, 9, pp.779~788 (2016)
50. Bork K, "Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate : a retrospective study", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 112, pp.58~64 (2011)
51. Farkas H, "The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures", J Oral Maxillofac Surg, 57, pp.404~408 (1999)
52. Magerl M, "Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema : findings from an international patient registry", Ann Allergy Asthma Immunol, 118, pp.110~112 (2017)
53. Nanda MK, "A cross-sectional questionnaire assessing patient and physician use of short-term prophylaxis for hereditary angioedema", Ann Allergy Asthma Immunol, 113, pp.198~203 (2014)
54. Valerieva A, "Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema", J Allergy Clin Immunol Pract, 8, pp.799~802 (2020)
55. Craig T, "Long-term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiency", Ann Allergy Asthma Immunol, 121, pp.673~679 (2018)
56. Farkas H, "Risk of thromboembolism in patients with hereditary angioedema treated with plasma-derived C1-inhibitor", Allergy Asthma Proc, 37, pp.164~170 (2016)
57. Riedl MA, "Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks", Allergy, 75, pp.2879~2887 (2020)
58. Bork K, "Benefits and risks of danazol in hereditary angioedema : a long-term survey of 118 patients", Ann Allergy Asthma Immunol, 100, pp.153~161 (2008)
59. Bouillet L, "Hereditary angioedema in women : specific challenges", Immunol Allergy Clin North Am, 33, pp.505~511 (2013)
60. Johnston DT, "Androgen use in hereditary angioedema : a critical appraisal and approaches to transitioning from androgens to other therapies", Allergy Asthma Proc, 42, pp.22~29 (2021)
61. Lundh B, "Tranexamic acid in hereditary angioneurotic edema--a progress report", N Engl J Med, 288, pp.53~ (1973)
62. Frank MM, "Update on preventive therapy(prophylaxis)of hereditary angioedema", Allergy Asthma Proc, 32, pp.17~21 (2011)
63. Kulthanan K, "Angioedema quality of life questionnaire(AE-QoL)-interpretability and sensitivity to change", Health Qual Life Outcomes, 17, pp.160~ (2019)
64. Mendivil J, "Clinical characteristics and burden of illness in patients with hereditary angioedema : findings from a multinational patient survey", Orphanet J Rare Dis, 16, pp.94~ (2021)
65. Weller K, "The Angioedema Quality of Life Questionnaire(AE-QoL)-assessment of sensitivity to change and minimal clinically important difference", Allergy, 71, pp.1203~1209 (2016)
66. Weller K, "Development and construct validation of the angioedema quality of life questionnaire", Allergy, 67, pp.1289~1298 (2012)

관련 논문AI추천